Carmat pumps up capital
Carmat, the French developer of the world’s most advanced artificial heart and one of Europe’s best IPO performers of the last year, completed a €29.3m rights issue after recording a large over-subscription, the company said on Monday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts